35 / 56
35
Scientific programme
Sunday, 23 April 2017
PL-05
Plenary Session
08:30–10:30
Ballroom BC
New advances in ADHD diagnosis
Chairs:
D. Quinn, Canada
L. A. Rohde, Brazil
PL-05-001 Is there clinical relevance in recognizing
subthreshold ADHD?
J. Biederman, USA
PL-05-002 Is there a real adult onset-ADHD disorder?
L. A. Rohde, Brazil
PL-05-003 Disentangling differences between
sluggish cognitive tempo and ADHD
without hyperactivity
S. Becker, USA
PL-05-004 What is the relation between ADHD and
other neurodevelopmental disorders
such as autism and schizophrenia?
J. Buitelaar, The Netherlands
10:30–11:00
Break
PL-06
Plenary Session
11:00–13:00
Ballroom BC
New advances in treatment of ADHD
Chairs:
R. Tannock, Canada
A. Warnke, Germany
PL-06-001 Is there any role for mindfulness in the
treatment of ADHD?
J. T. Mitchell, USA
PL-06-002 Do we need new drugs or new targets for
improving treatment of ADHD patients?
M. Stein, USA
PL-06-003 ADHD in the era of the connectome:
How psychostimulants modify network
structure among brain systems?
D. Fair, USA
PL-06-004 How far along we are towards devel-
oping a biomarker-driven personalized
approach to ADHD treatment?
J. Newcorn, USA
Closing Ceremony
13:00–13:30
Ballroom BC
l
Congress summary
l
Presentation of best poster awards
l
Announcement of the
7
th
ADHD World Congress 2019